USPTO serial 87243174
AEVI GENOMIC MEDICINE
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- CHISOLM, KEVON
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with AEVI GENOMIC MEDICINE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Monica Riva Talley
MONICA RIVA TALLEY STERNE, KESSLER, GOLDSTEIN & FOX P.L.L.C.1100 NEW YORK AVENUE, N.W.WASHINGTON, DC 20005UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Reagents for research purposes; assays for research purposes | ACTIVE | — |
| 005 | Pharmaceutical products, namely, treatments for pediatric onset and rare and orphan disorders; biological and chemical preparations for medical and veterinary use; antibodies for medical and veterinary use; proteins, enzymes, and peptides for medical and veterinary use; small molecule drugs for use in treatments for pediatric onset and rare and orphan disorders; reagents for medical use; diagnostic reagents and diagnostic assays for medical use; therapeutic agents for use in treatments for pediatric onset and rare and orphan disorders; immunotherapeutics and immunologics for use in treatments for pediatric onset and rare and orphan disorders; viral, retroviral, and non-viral vectors for use in treatments for pediatric onset and rare and orphan disorders; vaccines; adjuvants; pharmaceutical preparations for the treatment of rare and difficult-to-treat diseases; biological materials, namely, genetically modified autologous tissue implants, intended to produce proteins for therapeutic uses | ACTIVE | — |
| 010 | Medical devices and instruments for genetically modifying tissue | ACTIVE | — |
| 042 | Medical research; pharmaceutical drug development services; testing, inspection, research, or development of pharmaceutical preparations for gene therapy | ACTIVE | — |
| 044 | Medical services, namely, harvesting tissue from a patient, genetically modifying that tissue and then reintroducing it into the same patient for therapeutic purposes; medical services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Medgenics, Inc.
- Other trademarks owned by AEVI GENOMIC MEDICINE, INC.
- Other trademarks owned by AEVI GENOMIC MEDICINE, INC.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named AEVI GENOMIC MEDICINE
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 27, 2020 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jan 27, 2020 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jun 29, 2019 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jun 27, 2019 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Jun 27, 2019 | EXT4 | SOU EXTENSION 4 FILED | — |
| Jun 27, 2019 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Dec 29, 2018 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Dec 27, 2018 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Dec 27, 2018 | EXT3 | SOU EXTENSION 3 FILED | — |
| Dec 27, 2018 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jun 7, 2018 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jun 5, 2018 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Jun 5, 2018 | EXT2 | SOU EXTENSION 2 FILED | — |
| Jun 5, 2018 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jun 5, 2018 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Dec 15, 2017 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Dec 13, 2017 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Dec 13, 2017 | EXT1 | SOU EXTENSION 1 FILED | — |
| Dec 13, 2017 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jun 27, 2017 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| May 2, 2017 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| May 2, 2017 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| May 2, 2017 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 2, 2017 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 12, 2017 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 5, 2017 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Mar 28, 2017 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Mar 23, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 23, 2017 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Mar 21, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 21, 2017 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Mar 21, 2017 | ALIE | ASSIGNED TO LIE | — |
| Mar 20, 2017 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Mar 20, 2017 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Mar 20, 2017 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Mar 3, 2017 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 3, 2017 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 3, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 27, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 28, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 24, 2016 | NWAP | NEW APPLICATION ENTERED | — |